It’s Time to End Drug-Resistant Tuberculosis: The Case for Action

The cost of complacency: Economist Intelligence Unit report underscores major gaps in world’s response to drug-resistant TB.

Read More →

Ad-hoc donations of bedaquiline threaten sustainable, affordable access for patients

Advocates call on Indian Minister of Health to discontinue and phase out the drug donations of bedaquiline offered by Johnson & Johnson.

Read More →

An Activist’s Guide to Rifapentine

The guide details important efficacy, safety, and access information on rifapentine, a game-changing drug for treating TB infection in order to prevent active TB disease.

Read More →

Call to action: Pledge your support for the Global Fund

Sign the petition to urge governments to fully replenish the Global Fund!

Read More →

New report calls for urgent action to avert antimicrobial resistance crisis

International organizations unite on critical recommendations to combat drug-resistant infections and prevent staggering number of deaths each year.

Read More →

MSF: Johnson & Johnson should make TB drug available for all at $1/day

MSF protests at J&J’s annual shareholders meeting to demand a say in how lifesaving TB drug developed with considerable joint efforts, including public funding and MSF operational research, will be made available and affordable.

Read More →

TB LAM testing briefs

Two important tools for activists to use with donors and national TB programs in advocating for increased scale-up of the inexpensive, urine TB LAM test - an essential diagnostic test for TB in people living with HIV.

Read More →

TB CAB statement on M72/AS01E TB vaccine candidate development

Statement by the Global TB Community Advisory Board to the High-level consultation on accelerating the development of the M72/AS01E tuberculosis vaccine candidate

Read More →

Building an Evidence Base to Advocate for TB Research

TAG TB Project Co-Director Mike Frick discusses how public databases maintained by the NIH have been instrumental in supporting TAG's efforts to track global funding for TB research over time and hold governments and donors accountable to their TB research commitments.

Read More →

Experts set out targets to eliminate TB within a generation

A world free of TB is possible by 2045 if increased political will and financial resources are directed towards priority areas, according to a new Lancet Commission on TB.

Read More →

Page 2 of 98 · Total posts: 10

←First 1 2 3 Last→